Institutional investors, such as hedge funds and mutual funds, can significantly influence the stock price through large trading volumes.

Overall market sentiment, including economic conditions, interest rates, and geopolitical events, can impact investor confidence and trading behavior.

Company-specific news such as product announcements, clinical trial results, FDA approvals, partnerships, and financial performance reports play a crucial role in driving stock price changes.

Broader industry trends within the biotechnology sector, including regulatory changes, competitor activities, and technological advancements, can impact investor perception of the company's prospects.

Analyst ratings from investment banks and research firms can affect investor confidence and trading activity, often leading to price fluctuations.

The overall supply and demand for the stock, influenced by factors like short selling and share buybacks, can impact price movement.

The company's financial health, including revenue growth, profitability, cash flow, and debt levels, can affect investor sentiment and stock valuation.